A detailed history of Viking Fund Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Viking Fund Management LLC holds 133,250 shares of ABBV stock, worth $22.9 Million. This represents 4.44% of its overall portfolio holdings.

Number of Shares
133,250
Previous 142,250 6.33%
Holding current value
$22.9 Million
Previous $22 Million 10.07%
% of portfolio
4.44%
Previous 4.33%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $1.44 Million - $1.64 Million
-9,000 Reduced 6.33%
133,250 $24.3 Million
Q3 2023

Oct 16, 2023

BUY
$133.59 - $154.65 $1.08 Million - $1.25 Million
8,060 Added 6.01%
142,250 $21.2 Million
Q2 2023

Jul 20, 2023

BUY
$132.51 - $164.9 $820,236 - $1.02 Million
6,190 Added 4.84%
134,190 $18.1 Million
Q1 2023

Apr 17, 2023

BUY
$144.61 - $166.54 $578,440 - $666,160
4,000 Added 3.23%
128,000 $20.4 Million
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $414,930 - $497,610
3,000 Added 2.48%
124,000 $20.1 Million
Q3 2022

Oct 12, 2022

BUY
$134.21 - $153.93 $1.48 Million - $1.69 Million
11,000 Added 10.0%
121,000 $16.2 Million
Q2 2022

Jul 18, 2022

BUY
$137.62 - $174.96 $550,480 - $699,840
4,000 Added 3.77%
110,000 $16.8 Million
Q4 2021

Jan 14, 2022

BUY
$107.43 - $135.93 $214,860 - $271,860
2,000 Added 1.92%
106,000 $14.4 Million
Q3 2021

Oct 18, 2021

BUY
$106.4 - $120.78 $1.28 Million - $1.45 Million
12,000 Added 13.04%
104,000 $11.2 Million
Q2 2021

Jul 19, 2021

BUY
$105.21 - $117.21 $210,420 - $234,420
2,000 Added 2.22%
92,000 $10.4 Million
Q1 2021

Apr 26, 2021

BUY
$102.3 - $112.62 $306,900 - $337,860
3,000 Added 3.45%
90,000 $9.74 Million
Q4 2020

Jan 21, 2021

BUY
$80.49 - $108.67 $965,879 - $1.3 Million
12,000 Added 16.0%
87,000 $9.32 Million
Q2 2020

Jul 27, 2020

BUY
$73.37 - $98.18 $366,850 - $490,900
5,000 Added 7.14%
75,000 $7.36 Million
Q1 2020

Apr 13, 2020

BUY
$64.5 - $97.79 $774,000 - $1.17 Million
12,000 Added 20.69%
70,000 $5.33 Million
Q4 2019

Jan 15, 2020

BUY
$72.13 - $90.25 $721,300 - $902,500
10,000 Added 20.83%
58,000 $5.14 Million
Q3 2019

Oct 10, 2019

BUY
$62.98 - $75.72 $629,800 - $757,200
10,000 Added 26.32%
48,000 $3.64 Million
Q2 2019

Jul 16, 2019

BUY
$65.7 - $83.98 $1.71 Million - $2.18 Million
26,000 Added 216.67%
38,000 $2.76 Million
Q1 2019

Apr 15, 2019

BUY
$77.14 - $90.79 $154,280 - $181,580
2,000 Added 20.0%
12,000 $967,000
Q4 2018

Jan 23, 2019

BUY
$77.85 - $96.01 $778,500 - $960,100
10,000 New
10,000 $922,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Viking Fund Management LLC Portfolio

Follow Viking Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Viking Fund Management LLC with notifications on news.